STAT3 and glioblastoma: Furthermore, 14 genes were identified as potential prognostic markers associated with Th1 and Th2 responses and major inflammatory signaling pathways, including NF-κB and IL-6/STAT3 signaling: SLC11A1, TNFRSF1B, and LTBR were found to be especially promising predictors of the prognoses of GBM patients and could be used to develop effective GBM treatment strategies.